Jumpcode Genomics Secures $21M in Series B Funding
Investors include Baird Capital, Arboretum Ventures and LYZZ Capital; funding will accelerate commercialization of CRISPRclean™ next-generation sequencing technology Life sciences industry veteran Frank Witney joins Jumpcode Board of Directors Jumpcode opens new headquarters in San Diego biotech business hub SAN DIEGO, Calif. – Jan. 12, 2021 – Jumpcode Genomics – a genome technology company …
Jumpcode Genomics Secures $21M in Series B Funding Read More »